U.S. markets open in 2 hours 26 minutes

Kindred Bio: 4Q Earnings Snapshot

BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Monday reported a loss of $15.7 million in its fourth quarter.

The Burlingame, California-based company said it had a loss of 40 cents per share.

The biopharmaceutical company posted revenue of $1.4 million in the period.

For the year, the company reported that its loss widened to $61.4 million, or $1.59 per share. Revenue was reported as $4.3 million.

Kindred Bio shares have fallen 29% since the beginning of the year. In the final minutes of trading on Monday, shares hit $6, a fall of 34% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN